Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
1.720
-0.210 (-10.88%)
At close: Oct 23, 2026, 4:00 PM EDT
1.700
-0.020 (-1.16%)
After-hours: Oct 23, 2026, 4:00 PM EDT

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $660.60K in the quarter ending June 30, 2026, with 11.99% growth. This brings the company's total for the last twelve months to $3.26M, up 33.30% year-over-year. In the year 2025, Xenetic Biosciences had annual revenue of $2.98M with 19.04% growth. That makes Xenetic Biosciences the 41,216th largest company in the world by revenue and 5,543rd in the United States.

Revenue (ttm)
$3.26M
Revenue Growth
+33.30%
P/S Ratio
1.24
Revenue / Employee
$1,630,389
Employees
2
Market Cap
4.03M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.98M476.13K19.04%
Dec 31, 20242.50M-39.70K-1.56%
Dec 31, 20232.54M833.06K48.80%
Dec 31, 20221.71M546.23K47.06%
Dec 31, 20211.16M723.75K165.64%
Dec 31, 2020436.94K419.88K2,460.31%
Dec 31, 201917.07K--
Dec 31, 2018---
Dec 31, 20177.59M4.59M152.83%
Dec 31, 20163.00M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20131.00M706.40K240.60%
Dec 31, 2012293.60K--
Aug 31, 2012---